This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Catherine Ley, MS; Arthur L. Reingold, MD
University of California—Berkeley

Chinh Le, MD
Kaiser Permanente Medical Group Santa Rosa, Calif

JAMA. 1994;272(3):203.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We thank Mr Berardi and Dr Seder for their comments concerning our article on the use of Lyme disease serologic tests. Needless to say, we agree that a more specific and sensitive serologic test will yield results that are more useful to clinicians attempting to confirm or refute the diagnosis of Lyme disease, particularly in a patient with signs and symptoms compatible with either early-stage or late-stage Lyme disease. In fact, laboratory testing for Lyme disease at the facility we studied was subsequently changed to a whole-cell sonicate enzyme immunoassay, followed by Western blot testing of all positive specimens. In addition, we are currently involved in a collaborative study with the Centers for Disease Control and Prevention that is comparing these results with an experimental new ELISA test.

However, the purpose of our study was to examine the appropriateness and utility of Lyme disease serologic testing as currently . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?